BridgeMD
New treatment option for Ovarian Cancer
Official title Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)
ClinicalTrials.gov ID: NCT05606692
What this study is testing
What is Propofol 1%?
Propofol 1% is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for ovarian cancer.
Also referred to as ANESVAN INJECTION 10MG/ML (PROPOFOL) "CHI SHENG".
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Ⅶ. Study procedures (summary) 1.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80, women only
You may be able to join if
- Twenty to eighty-year-old.
- ASA class I-III.
- Patients undergoing elective craniotomy for primary ovarian tumors under general anesthesia.
You likely can't join if
- Severe mental disorder
- Poor liver function
- Pregnant or lactating women
- Morbid obesity
- Have a history of allergy to any drug used in this study
- Non-primary ovarian cancer surgery
See the full eligibility criteria
- Twenty to eighty-year-old.
- ASA class I-III.
- Patients undergoing elective craniotomy for primary ovarian tumors under general anesthesia.
- Severe mental disorder
- Poor liver function
- Pregnant or lactating women
- Morbid obesity
- Have a history of allergy to any drug used in this study
- Non-primary ovarian cancer surgery
- Undergoing ovarian cancer pathological section surgery
- Patients with incomplete medical records
- Combined with other surgeries, emergency surgeries
- Concomitant patients with other non-ovarian cancer therapy
- Patients receiving palliative treatment after ovarian cancer surgery
- During the maintenance period of anesthesia, propofol or sevoflurane should not be used as anesthetic drugs
- Intraoperative combined use of multiple anesthetics (such as ketamine, dexmedetomidine, other inhalation anesthetics)
- Those diagnosed with benign tumors before and after surgery
- Patients with metastases to the ovary
The study team makes the final eligibility decision.
Where it's taking place
- Kaohsiung City, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaohsiung City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.